Bright Minds Biosciences Stock Probability of Future Stock Price Finishing Over 3,570
| DRUG Stock | USD 35.33 2.95 9.11% |
Bright |
Bright Minds Target Price Odds to finish over 3,570
The tendency of Bright Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 35.33 | 90 days | 35.33 | about 23.31 |
Based on a normal probability distribution, the odds of Bright Minds to move above the current price in 90 days from now is about 23.31 (This Bright Minds Biosciences probability density function shows the probability of Bright Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Bright Minds Biosciences has a beta of -31.85 suggesting as returns on its benchmark rise, returns on holding Bright Minds Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Bright Minds is expected to outperform its benchmark. In addition to that Bright Minds Biosciences has an alpha of 28.574, implying that it can generate a 28.57 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Bright Minds Price Density |
| Price |
Predictive Modules for Bright Minds
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bright Minds Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bright Minds' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bright Minds Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bright Minds is not an exception. The market had few large corrections towards the Bright Minds' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bright Minds Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bright Minds within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 28.57 | |
β | Beta against Dow Jones | -31.85 | |
σ | Overall volatility | 21.57 | |
Ir | Information ratio | 0.14 |
Bright Minds Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bright Minds for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bright Minds Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bright Minds is way too risky over 90 days horizon | |
| Bright Minds appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (7.37 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (7.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Bright Minds has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from aol.com: Legislation introduced to reduce prescription drug shortages |
Bright Minds Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bright Stock often depends not only on the future outlook of the current and potential Bright Minds' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bright Minds' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.7 M | |
| Cash And Short Term Investments | 6.7 M |
Bright Minds Technical Analysis
Bright Minds' future price can be derived by breaking down and analyzing its technical indicators over time. Bright Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bright Minds Biosciences. In general, you should focus on analyzing Bright Stock price patterns and their correlations with different microeconomic environments and drivers.
Bright Minds Predictive Forecast Models
Bright Minds' time-series forecasting models is one of many Bright Minds' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bright Minds' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Bright Minds Biosciences
Checking the ongoing alerts about Bright Minds for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bright Minds Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bright Minds is way too risky over 90 days horizon | |
| Bright Minds appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (7.37 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (7.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Bright Minds has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from aol.com: Legislation introduced to reduce prescription drug shortages |
Check out Bright Minds Backtesting, Bright Minds Valuation, Bright Minds Correlation, Bright Minds Hype Analysis, Bright Minds Volatility, Bright Minds History as well as Bright Minds Performance. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.29) | Return On Equity (0.52) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.